Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tong

Showing results (101-110 of 253) with videos related to

Pageof 26
Sort By:
Placenta|May 6, 2021
Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissuesFiona Brownfoot, Natalie Binder, Roxanne Hastie, et al.
JAMA Network Open|November 17, 2023
Prevalence of Perinatal Anxiety and Related Disorders in Low- and Middle-Income Countries: A Systematic Review and Meta-AnalysisAlexandra Roddy Mitchell, Hannah Gordon, Jessica Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2013
Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restrictionClare L Whitehead, Susan P Walker, Louie Ye, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2015
Human HtrA4 Expression Is Restricted to the Placenta, Is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial DysfunctionHarmeet Singh, Min Zhao, Qi Chen, et al.
Gynecologic Oncology Reports|January 10, 2022
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancerNatalie J Hannan, Paul A Cohen, Sally Beard, et al.
Molecular and Cellular Endocrinology|July 11, 2015
YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsiaFiona C Brownfoot, Stephen Tong, Natalie J Hannan, et al.
Open Heart|March 13, 2023
Patients' understanding of long-term cardiovascular risks and associated health-seeking behaviours after pre-eclampsiaJessica Atkinson, William Wei, Stephanie Potenza, et al.
Plos One|June 11, 2016
Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in PreeclampsiaAneta Dobierzewska, Macarena Palominos, Marianela Sanchez, et al.
Biomedical Reports|April 29, 2017
The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancerAdam Pendlebury, Natalie J Hannan, Natalie Binder, et al.
Clinical Endocrinology|June 3, 2009
Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestationKelly Tierney, Pavitra Delpachitra, Mathis Grossmann, et al.
Pageof 26

Showing results (101-110 of 253) with videos related to

Sort By:
Pageof 26
Placenta|May 6, 2021
Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissuesFiona Brownfoot, Natalie Binder, Roxanne Hastie, et al.
JAMA Network Open|November 17, 2023
Prevalence of Perinatal Anxiety and Related Disorders in Low- and Middle-Income Countries: A Systematic Review and Meta-AnalysisAlexandra Roddy Mitchell, Hannah Gordon, Jessica Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2013
Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restrictionClare L Whitehead, Susan P Walker, Louie Ye, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2015
Human HtrA4 Expression Is Restricted to the Placenta, Is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial DysfunctionHarmeet Singh, Min Zhao, Qi Chen, et al.
Gynecologic Oncology Reports|January 10, 2022
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancerNatalie J Hannan, Paul A Cohen, Sally Beard, et al.
Molecular and Cellular Endocrinology|July 11, 2015
YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsiaFiona C Brownfoot, Stephen Tong, Natalie J Hannan, et al.
Open Heart|March 13, 2023
Patients' understanding of long-term cardiovascular risks and associated health-seeking behaviours after pre-eclampsiaJessica Atkinson, William Wei, Stephanie Potenza, et al.
Plos One|June 11, 2016
Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in PreeclampsiaAneta Dobierzewska, Macarena Palominos, Marianela Sanchez, et al.
Biomedical Reports|April 29, 2017
The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancerAdam Pendlebury, Natalie J Hannan, Natalie Binder, et al.
Clinical Endocrinology|June 3, 2009
Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestationKelly Tierney, Pavitra Delpachitra, Mathis Grossmann, et al.
Pageof 26